PMCB icon

PharmaCyte Biotech
PMCB

Overview Fund Activity

22 hedge funds and large institutions have $4.42M invested in PharmaCyte Biotech in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
–
Closed
–
Calls
$234K
Puts
$140K
Net Calls
+$94K
Net Calls Change
+$94K

Top Buyers

1
SM
1
Sabby Management
Florida
$3.2M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$424K
3
SSA
3
Schonfeld Strategic Advisors
New York
$280K
4
SFI
4
Susquehanna Fundamental Investments
Pennsylvania
$158K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$147K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
CG
26
Cutler Group
California
$0 78 +78 New
1
2